Progress in the application of dupilumab for non-atopic dermatitis
Dupilumab inhibits Th2-mediated inflammatory responses by specifically blocking the signaling pathways of interleukin-4 and interleukin-13. Recently, in addition to its approved indication for the treatment of moderate-to-severe atopic dermatitis, dupilumab has also shown efficacy in treating other...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Chinês |
| Опубліковано: |
editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology
2026-01-01
|
| Серія: | Pifu-xingbing zhenliaoxue zazhi |
| Предмети: | |
| Онлайн доступ: | http://pfxbzlx.gdvdc.com/CN/10.3969/j.issn.1674-8468.2026.01.012 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|